Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

»ýÁ㠽ż¼Æ÷¾Ï ¼¼Æ÷ÁÖ µ¿¼Ò ÀÌ½Ä ¸¶¿ì½º ¸ðµ¨¿¡¼­ ¼±ÅÃÀû Ç¥ÇÇ ¼ºÀå ÀÎÀÚ ¼ö¿ëü tyrosine kinase inhibitor (ZD1839)ÀÇ Ç×Ç÷°ü½Å»ý È¿°ú Anti-angiogenic Effect of Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor(ZD1839) against Murine Renal Cell Carcinoma Orthotopic Model

´ëÇѺñ´¢±â°úÇÐȸÁö 2004³â 45±Ç 3È£ p.255 ~ 262
¼Ò¼Ó »ó¼¼Á¤º¸
¿ÀÇý¿µ/Oh HY ±Ç¼ö¹Ì/±è¼±ÀÏ/È«¼ºÁØ/Kwon SM/Kim SI/Hong SJ

Abstract

[ÃʷϾøÀ½:No abstract]

Å°¿öµå

Renal cell carcinoma;Pathologic neovascularization;ZD1839;Genistein

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS